Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
I am interested in...
Wayfinder menu
VIVO
Research Home
Departments
SPORE in Prostate Cancer
Explore this Website
I am interested in...
Wayfinder menu
VIVO
Research Home
Departments
Home
About Us
Toggle About Us menu options
Affiliations
Donate
Resources
Job Opportunities
Contact Us
Research
Toggle Research menu options
Project 1
Project 2
Project 3
Project 4
Programs
Toggle Programs menu options
Career Enhancement Program
Toggle Career Enhancement Program menu options
2023 CEP Projects
Developmental Research Program
Toggle Developmental Research Program menu options
2023 DRP Awardee Projects
Cores
Toggle Cores menu options
Administrative Core
Biospecimen & Pathology
Computational Biology - Biostatistics
Investigators
Publications
News
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Research
Programs
Cores
Investigators
Publications
News
Home
Publications
Publications
Found 53 results
Author
Title
Type
Year
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
L
Lehmann GL
,
Hanke-Gogokhia C
,
Hu Y
,
Bareja R
,
Salfati Z
,
Ginsberg M
,
Nolan DJ
,
Mendez-Huergo SP
,
Dalotto-Moreno T
,
Wojcinski A
et al.
. 2020.
Single-cell profiling reveals an endothelium-mediated immunomodulatory pathway in the eye choroid.
.
J Exp Med. 217(6)
K
Kolin DA
,
Kulm S
,
Elemento O
. 2020.
Clinical and Genetic Characteristics of Covid-19 Patients from UK Biobank.
.
medRxiv.
G
Guo H
,
Ci X
,
Ahmed M
,
Hua JTony
,
Soares F
,
Lin D
,
Puca L
,
Vosoughi A
,
Xue H
,
Li E
et al.
. 2019.
ONECUT2 is a driver of neuroendocrine prostate cancer.
.
Nat Commun. 10(1):278.
Grbesa I
,
Augello MA
,
Liu D
,
McNally DR
,
Gaffney CD
,
Huang D
,
Lin K
,
Ivenitsky D
,
Goueli R
,
Robinson BD
et al.
. 2021.
Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity.
.
Cell Rep. 36(10):109625.
Gjyrezi A
,
Xie F
,
Voznesensky O
,
Khanna P
,
Calagua C
,
Bai Y
,
Kung J
,
Wu J
,
Corey E
,
Montgomery B
et al.
. 2020.
Taxane resistance in prostate cancer is mediated by decreased drug-target engagement.
.
J Clin Invest. 130(6):3287-3298.
Gilvary C
,
Elkhader J
,
Madhukar N
,
Henchcliffe C
,
Goncalves MD
,
Elemento O
. 2020.
A machine learning and network framework to discover new indications for small molecules.
.
PLoS Comput Biol. 16(8):e1008098.
Gerke T
,
Beltran H
,
Wang X
,
Lee G-SMary
,
Sboner A
,
R Karnes J
,
Klein EA
,
Davicioni E
,
Yousefi K
,
Ross AE
et al.
. 2019.
Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer.
.
Cancer Epidemiol Biomarkers Prev. 28(3):584-590.
E
Elfandy H
,
Armenia J
,
Pederzoli F
,
Pullman E
,
Pertega-Gomes N
,
Schultz N
,
Viswanathan K
,
Vosoughi A
,
Blattner M
,
Stopsack KH
et al.
. 2019.
Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.
.
Mol Cancer Res. 17(2):446-456.
D
Davies A
,
Conteduca V
,
Zoubeidi A
,
Beltran H
. 2019.
Biological Evolution of Castration-resistant Prostate Cancer.
.
Eur Urol Focus. 5(2):147-154.
C
Cotter KA
,
Gallon J
,
Uebersax N
,
Rubin P
,
Meyer KD
,
Piscuoglio S
,
Jaffrey SR
,
Rubin MA
. 2021.
Mapping of m6A and Its Regulatory Targets in Prostate Cancer Reveals a METTL3-Low Induction of Therapy Resistance.
.
Mol Cancer Res. 19(8):1398-1411.
Conteduca V
,
Ku S-Y
,
Fernandez L
,
Dago-Rodriquez A
,
Lee J
,
Jendrisak A
,
Slade M
,
Gilbertson C
,
Manohar J
,
Sigouros M
et al.
. 2021.
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis.
.
NPJ Precis Oncol. 5(1):76.
Conteduca V
,
Beltran H
,
Nanus DM
,
Tagawa ST
,
Mosquera JMiguel
,
Sboner A
,
Elemento O
,
Ku S-Y
,
Puca L
,
Slade M
et al.
. 2020.
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy.
.
Mol Cancer Ther. 19(5):1157-1164.
Conteduca V
,
Oromendia C
,
Eng KW
,
Bareja R
,
Sigouros M
,
Molina A
,
Faltas BM
,
Sboner A
,
Mosquera JMiguel
,
Elemento O
et al.
. 2019.
Clinical features of neuroendocrine prostate cancer.
.
Eur J Cancer. 121:7-18.
Conteduca V
,
Sigouros M
,
Sboner A
,
Pritchard CC
,
Beltran H
. 2018.
BRCA2-Associated Prostate Cancer in a Patient With Spinal and Bulbar Muscular Atrophy.
.
JCO Precis Oncol. 2
Choudhury AD
,
Beltran H
. 2019.
Retinoblastoma Loss in Cancer: Casting a Wider Net.
.
Clin Cancer Res. 25(14):4199-4201.
B
Butler LM
,
Perone Y
,
Dehairs J
,
Lupien LE
,
de Laat V
,
Loda M
,
Talebi A
,
Kinlaw WB
,
Swinnen JV
. 2020.
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.
.
Adv Drug Deliv Rev. 159:245-293.
Brady NJ
,
Bagadion AM
,
Singh R
,
Conteduca V
,
Van Emmenis L
,
Arceci E
,
Pakula H
,
Carelli R
,
Khani F
,
Bakht M
et al.
. 2021.
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer.
.
Nat Commun. 12(1):3372.
Boehm KMichael
,
Bhinder B
,
Raja VJoseph
,
Dephoure N
,
Elemento O
. 2019.
Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome.
.
BMC Bioinformatics. 20(1):7.
Berger A
,
Brady NJ
,
Bareja R
,
Robinson B
,
Conteduca V
,
Augello MA
,
Puca L
,
Ahmed A
,
Dardenne E
,
Lu X
et al.
. 2019.
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.
.
J Clin Invest. 129(9):3924-3940.
Berchuck JE
,
Viscuse PV
,
Beltran H
,
Aparicio A
. 2021.
Clinical considerations for the management of androgen indifferent prostate cancer.
.
Prostate Cancer Prostatic Dis. 24(3):623-637.
Beltran H
,
Oromendia C
,
Danila DC
,
Montgomery B
,
Hoimes C
,
Szmulewitz RZ
,
Vaishampayan U
,
Armstrong AJ
,
Stein M
,
Pinski J
et al.
. 2018.
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.
.
Clin Cancer Res.
Beltran H
,
Nanus DM
,
Sboner A
,
Mosquera JMiguel
,
Elemento O
,
Tagawa ST
,
Demichelis F
,
Romanel A
,
Conteduca V
,
Casiraghi N
et al.
. 2020.
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
.
J Clin Invest. 130(4):1653-1668.
Beltran H
,
Demichelis F
. 2021.
Therapy considerations in neuroendocrine prostate cancer: what next?
Endocr Relat Cancer. 28(8):T67-T78.
Barbieri CE
,
Sboner A
,
Liu D
,
Ben-Salem S
,
Hu Q
,
Liu Y
,
Alshalalfa M
,
Zhao X
,
Wang I
,
Venkadakrishnan VBalaji
et al.
. 2020.
Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes.
.
Eur Urol Open Sci. 22:34-44.
A
Aytes A
,
Giacobbe A
,
Mitrofanova A
,
Ruggero K
,
Cyrta J
,
Arriaga J
,
Palomero L
,
Farran-Matas S
,
Rubin MA
,
Shen MM
et al.
. 2018.
NSD2 is a conserved driver of metastatic prostate cancer progression.
.
Nat Commun. 9(1):5201.
« first
‹ previous
1
2
(current)
3
next ›
last »